SpyGlass Pharma, Inc. (SGP) — Net Asset Momentum
SpyGlass Pharma, Inc. (SGP) recorded a net asset momentum of -63.4% as of December 2025, with net assets of $-98.84 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of SpyGlass Pharma, Inc. for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
SpyGlass Pharma, Inc. Net Asset Momentum (2023–2025)
This chart tracks SpyGlass Pharma, Inc.'s year-over-year net asset growth across 3 annual reporting periods from 2023 to 2025. The most recent momentum reading is -63.4%, with net assets of $-98.84 Million USD as of December 2025. Check SGP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for SpyGlass Pharma, Inc. (2023–2025)
The table below shows the complete annual net asset history for SpyGlass Pharma, Inc. from 2023 to 2025, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see SGP company net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-98.84 Million | $115.87 Million | $214.70 Million | ▼ -63.4% |
| 2024 | $-60.47 Million | $23.32 Million | $83.79 Million | ▼ -83.3% |
| 2023 | $-32.99 Million | $41.15 Million | $74.13 Million | — |